How did BPC 157 become the wellness industry's star peptide? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 + TB 500 Combination: Benefits, Differences, and When to Use Both Revolution Health & Wellness FDA Peptide Reclassification 2026: What It Means for Providers